Latest Vivo Capital, LLC Stock Portfolio
Vivo Capital, LLC Performance:
2025 Q3: 20.16%YTD: 43.76%2024: 7.37%
Performance for 2025 Q3 is 20.16%, and YTD is 43.76%, and 2024 is 7.37%.
About Vivo Capital, LLC and 13F Hedge Fund Stock Holdings
Vivo Capital, LLC is a hedge fund based in PALO ALTO, CA. On 28-Apr-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $5.4 Billions. In it's latest 13F Holdings report, Vivo Capital, LLC reported an equity portfolio of $1.2 Billions as of 30 Sep, 2025.
The top stock holdings of Vivo Capital, LLC are SLNO, VRNA, CDTX. The fund has invested 12.4% of it's portfolio in SOLENO THERAPEUTICS INC and 12% of portfolio in VERONA PHARMA PLC.
The fund managers got completely rid off COMPASS PATHWAY PLC (CMPS), IO BIOTECH INC (IOBT) and CELCUITY INC (CELC) stocks. They significantly reduced their stock positions in CYTOMX THERAPEUTICS INC (CTMX) and SOLENO THERAPEUTICS INC (SLNO). Vivo Capital, LLC opened new stock positions in ABIVAX SA - ADR, SAB BIOTHERAPEUTICS INC (SABS) and PEPGEN INC (PEPG). The fund showed a lot of confidence in some stocks as they added substantially to COGENT BIOSCIENCES INC (COGT), DYNE THERAPEUTICS INC (DYN) and BRIGHT MINDS BIOSCIENCES INC.
The top stock holdings of Vivo Capital, LLC are SLNO, VRNA, CDTX. The fund has invested 12.4% of it's portfolio in SOLENO THERAPEUTICS INC and 12% of portfolio in VERONA PHARMA PLC.
The fund managers got completely rid off COMPASS PATHWAY PLC (CMPS), IO BIOTECH INC (IOBT) and CELCUITY INC (CELC) stocks. They significantly reduced their stock positions in CYTOMX THERAPEUTICS INC (CTMX) and SOLENO THERAPEUTICS INC (SLNO). Vivo Capital, LLC opened new stock positions in ABIVAX SA - ADR, SAB BIOTHERAPEUTICS INC (SABS) and PEPGEN INC (PEPG). The fund showed a lot of confidence in some stocks as they added substantially to COGENT BIOSCIENCES INC (COGT), DYNE THERAPEUTICS INC (DYN) and BRIGHT MINDS BIOSCIENCES INC.
Vivo Capital, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Vivo Capital, LLC made a return of 20.16% in the last quarter. In trailing 12 months, it's portfolio return was 27.44%.
New Buys
| Ticker | $ Bought |
|---|---|
| abivax sa - adr | 30,505,000 |
| sab biotherapeutics inc | 22,954,200 |
| dianthus therapeutics inc | 13,929,800 |
| lb pharmaceuticals inc | 12,632,000 |
| camp4 therapeutics inc | 11,764,700 |
| pepgen inc | 10,741,500 |
| eupraxia pharmaceuticals inc | 7,965,000 |
| monopar therapeutics inc | 7,391,140 |
New stocks bought by Vivo Capital, LLC
Additions
| Ticker | % Inc. |
|---|---|
| cogent biosciences inc | 148 |
| dyne therapeutics inc | 134 |
| bright minds biosciences inc | 99.39 |
| verastem inc | 71.92 |
| compass therapeutics inc | 57.95 |
| unicycive therapeutics | 57.42 |
| erasca inc | 37.25 |
| tango therapeutics inc | 29.45 |
Additions to existing portfolio by Vivo Capital, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| cytomx therapeutics inc | -50.00 |
| soleno therapeutics inc | -42.44 |
Vivo Capital, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| io biotech inc | -8,581,080 |
| compass pathway plc | -9,414,680 |
| celcuity inc | -8,150,180 |
Vivo Capital, LLC got rid off the above stocks
Sector Distribution
Vivo Capital, LLC has about 80.1% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 80.1 |
| Others | 19.9 |
Market Cap. Distribution
Vivo Capital, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 32.6 |
| MICRO-CAP | 26.4 |
| UNALLOCATED | 19.9 |
| MID-CAP | 17.6 |
| NANO-CAP | 3.5 |
Stocks belong to which Index?
About 32.8% of the stocks held by Vivo Capital, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 67.2 |
| RUSSELL 2000 | 32.8 |
Vivo Capital, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Vivo Capital, LLC
Vivo Capital, LLC has 47 stocks in it's portfolio. About 58% of the portfolio is in top 10 stocks. SLNO proved to be the most loss making stock for the portfolio. CDTX was the most profitable stock for Vivo Capital, LLC last quarter.
Last Reported on: 14 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABEO | abeona therapeutics, inc. | 0.78 | 1,842,750 | 9,729,720 | unchanged | 0.00 | ||
| ACRS | aclaris therapeutics, inc. | 1.36 | 8,888,890 | 16,888,900 | unchanged | 0.00 | ||
| AKRO | akero therapeutics inc | 1.66 | 434,689 | 20,639,000 | unchanged | 0.00 | ||
| ATXS | astria therapeutics inc | 0.91 | 1,552,680 | 11,303,500 | unchanged | 0.00 | ||
| BOLT | bolt therapeutics inc | 0.07 | 176,064 | 936,660 | unchanged | 0.00 | ||
| CDTX | cidara therapeutics, inc. | 10.11 | 1,311,420 | 125,582,000 | unchanged | 0.00 | ||
| CELC | celcuity inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CMPS | compass pathway plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CMPX | compass therapeutics inc | 2.69 | 9,545,470 | 33,409,100 | added | 57.95 | ||
| COGT | cogent biosciences inc | 3.22 | 2,789,140 | 40,052,000 | added | 148 | ||
| CRVS | corvus pharmaceuticals holdings | 1.32 | 2,234,570 | 16,468,800 | unchanged | 0.00 | ||
| CTMX | cytomx therapeutics inc | 0.74 | 2,884,620 | 9,201,920 | reduced | -50.00 | ||
| DBVT | dbv technologies sa | 0.85 | 1,054,510 | 10,545,100 | unchanged | 0.00 | ||
| DCTH | delcath systems, inc. | 0.49 | 569,526 | 6,122,400 | unchanged | 0.00 | ||
| DTIL | precision biosciences inc | 0.00 | 4,675 | 25,806 | unchanged | 0.00 | ||
| DYN | dyne therapeutics inc | 2.66 | 2,614,960 | 33,079,200 | added | 134 | ||
| ERAS | erasca inc | 1.63 | 9,273,430 | 20,216,100 | added | 37.25 | ||
| ETNB | 89bio inc | 0.45 | 376,804 | 5,539,020 | unchanged | 0.00 | ||
| GERN | geron corp | 3.00 | 27,225,300 | 37,298,600 | unchanged | 0.00 | ||
| IOBT | io biotech inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||